Jubilant Organosys gets Canada nod for drug

Jubilant Organosys gets Canada nod for drug
Comment E-mail Print Share
First Published: Mon, Mar 02 2009. 10 16 PM IST
Updated: Mon, Mar 02 2009. 10 16 PM IST
Mumbai: Drug maker Jubilant Organosys Ltd said on Monday its Canada unit, Draxis, has received safety approval for generic sestamibi from Health Canada.
Sestamibi is used in the treatment of myocardial infection, ischemic heart disease and coronary artery disease, the company said in a statement.
The promoters of HT Media Ltd, which publishes Mint, and promoters of Jubilant Organosys Ltd are closely related. The companies have no promoter cross-holdings.
Comment E-mail Print Share
First Published: Mon, Mar 02 2009. 10 16 PM IST